ARTICLE | Clinical News
Yervoy ipilimumab regulatory update
November 9, 2015 8:00 AM UTC
FDA approved an sBLA from Bristol-Myers Squibb for Yervoy ipilimumab as adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of >1 mm who have und...